Treatment of tuberculosis in developing countries.
Pozniak
A
A
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003906:Developing Countries; D003875:Drug Eruptions / Q000209:etiology; D004359:Drug Therapy, Combination; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D013636:Tanzania; D013828:Thioacetazone / Q000009:adverse effects*; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D013828:Thioacetazone